Login / Signup

Time to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen.

Matthew D HoKiang-Teck Jerry YeoScott E Eggener
Published in: American journal of clinical pathology (2023)
Keyphrases
  • prostate cancer
  • radical prostatectomy
  • adverse drug